Literature DB >> 20135056

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.

Gregory Y H Lip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20135056     DOI： 10.1160/TH10-01-0038

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  6 in total

1.  Stroke Prophylaxis for Atrial Fibrillation? To Prescribe or Not to Prescribe-A Qualitative Study on the Decisionmaking Process of Emergency Department Providers.

Authors:  Bory Kea; Tahroma Alligood; Cassandra Robinson; Josephine Livingston; Benjamin C Sun
Journal:  Ann Emerg Med       Date:  2019-05-09       Impact factor: 5.721

2.  Are family physicians using the CHADS₂score? Is it useful for assessing risk of stroke in patients with atrial fibrillation?

Authors:  Douglas Klein; Max Levine
Journal:  Can Fam Physician       Date:  2011-08       Impact factor: 3.275

3.  Oral antiplatelet therapy in acute coronary syndromes: update 2012.

Authors:  Thomas Höchtl; Peter R Sinnaeve; Tom Adriaenssens; Kurt Huber
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-04

4.  Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.

Authors:  S Horstmann; T Rizos; M Lauseker; M Möhlenbruch; E Jenetzky; W Hacke; Th Steiner; R Veltkamp
Journal:  J Neurol       Date:  2013-05-05       Impact factor: 4.849

5.  Atrial fibrillation: its prevalence and risk factor profile in the German general population.

Authors:  Renate B Schnabel; Sandra Wilde; Philipp S Wild; Thomas Munzel; Stefan Blankenberg
Journal:  Dtsch Arztebl Int       Date:  2012-04-20       Impact factor: 5.594

6.  Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes.

Authors:  T Yetgin; M M J M van der Linden; A G de Vries; P C Smits; E Boersma; R-J M van Geuns; F Zijlstra
Journal:  Neth Heart J       Date:  2014-02       Impact factor: 2.380
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.